PR Newswire TechnologyCodex · 实盘不做把握 8/10
北京时间·🕒 发布 10:00:00时区推断·⟳ 抓取 10:02:29·⚡ 决策 07-11 10:06:13 +3m44s·108.5 天前
ClaimsFiler提醒Erasca投资者证券集体诉讼首席原告申请截止日
这是一条律所/索赔服务机构发布的股东诉讼提醒广告，核心信息是首席原告申请截止日，并非新的监管处罚、临床失败或公司经营增量信息。
📄 原文PR Newswire Technology↗ 原文
NEW ORLEANS, July 10, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that…
不做 Erasca（ERAS.US）
本条是股东诉讼截止日提醒和律所获客信息，不是新的经营、临床、监管或财务利空；做空催化强度不足且默认不开空。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-11 · 扩散 low · price-in 风险 medium ↗
关键理由
- 这是一条律所/索赔服务机构发布的股东诉讼提醒广告，核心信息是首席原告申请截止日，并非新的监管处罚、临床失败或公司经营增量信息。
主要风险
- 若后续法院文件或公司披露出现新的重大证据，才可能重新评估；本条提醒本身不足以形成交易催化。
原文全文
展开原文 · 2,183 字
NEW ORLEANS, July 10, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 10, 2026 to file lead plaintiff applications in a securities class action lawsuit against Erasca, Inc. (NasdaqGS: ERAS) ("Erasca" or the "Company"), if they purchased or otherwise acquired the Company's securities between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of California.
Get Help
Erasca investors should visit us at https://www.claimsfiler.com/cases/nasdaq-eras/?prs=prn or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Erasca and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the preclinical data for the Company's ERAS-0015 product, a pan-RAS molecular glue for the treatment of patients with RAS-mutated solid tumors, was based on improper comparisons to Revolution Medicines, Inc. and placed Erasca at risk of violating patent and trade secret protections; and (ii) based on the foregoing, the defendants lacked a reasonable basis for their positive statements related to ERAS-0015.
The case is Cheng v. Erasca, Inc., No. 26-cv-03481.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
SOURCE ClaimsFiler
Get Help
Erasca investors should visit us at https://www.claimsfiler.com/cases/nasdaq-eras/?prs=prn or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Erasca and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the preclinical data for the Company's ERAS-0015 product, a pan-RAS molecular glue for the treatment of patients with RAS-mutated solid tumors, was based on improper comparisons to Revolution Medicines, Inc. and placed Erasca at risk of violating patent and trade secret protections; and (ii) based on the foregoing, the defendants lacked a reasonable basis for their positive statements related to ERAS-0015.
The case is Cheng v. Erasca, Inc., No. 26-cv-03481.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
SOURCE ClaimsFiler
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。